WJBF – New Study Highlights Cannabis Safety Clinical Guidelines
This article discusses cannabis safety clinical guidelines based on a new study from Washington State University. The research holds high clinical relevance for evidence-based medicine. Understanding these guidelines is essential for informed clinical…
New Washington State University Study on Smoking Cannabis: Clinical Review
The smoking cannabis study Washington State provides important clinical insights from 2026 research. This study highlights key considerations for cannabis use and patient care. Understanding these findings helps inform evidence-based clinical practice.
Cannabis Retailer Advice on Blunt, Tobacco, and Cannabis Use During Pregnancy
Pregnancy cannabis counseling patient safety is critical as many pregnant individuals seek advice from cannabis retailers. This study highlights the risks of prenatal cannabis use and blunt tobacco. Evidence-based guidance is essential for informed…
Cannabinoids and Drug-Drug Pharmacokinetic Interactions: Deciphering the Risks
Cannabinoid drug interactions clinical evidence highlights the importance of understanding how cannabinoids affect other medications. These interactions can alter drug metabolism and efficacy. Clinicians must consider these risks for safe prescribing and…
Association of Multimodal Cannabis Use with Adverse Events among Adolescents and Young Adults.
Multimodal cannabis consumption risks are rising among adolescents and young adults. This study reveals that using multiple cannabis methods correlates with increased adverse events. Understanding these risks is crucial for effective harm reduction…
Specific Forms of Substance Misuse Increase Stroke Risk – Pulmonology Advisor
Stroke risk substance use varies depending on the specific substance involved. Different forms of substance misuse increase stroke risk through distinct mechanisms. Understanding these differences is crucial for accurate risk assessment and patient…
Understanding Cannabis Use for Symptom Management in Cancer Patients
Cannabis use cancer symptom management is increasingly common among patients undergoing treatment. The National Cancer Institute supports studies to evaluate both benefits and harms. These efforts aim to provide rigorous data to guide clinical…
SAFE GC Coalition: Cannabis Hyperemesis Syndrome on the Rise in Glen Cove
Cannabis hyperemesis syndrome increasing is a critical clinical concern linked to chronic cannabis use. This syndrome causes severe cyclical vomiting often misdiagnosed in emergency settings. Awareness of cannabis hyperemesis syndrome increasing is…
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Topical cannabis balms AIMSS treatment was evaluated in a randomized trial among breast cancer survivors experiencing musculoskeletal pain. The study assessed feasibility, tolerability, and preliminary efficacy of CBD and THC balms. Results provide early…
Endocannabinoid System & PTSD: Cannabis in Dual Diagnosis
Cannabis use and trauma-focused treatment are critical considerations in managing PTSD with co-occurring substance use disorders. Evidence shows trauma-focused treatments remain effective despite cannabis use. This supports continuing evidence-based care…